Startups
2021
NUAGE THERAPEUTICS SLNuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs.
Address
Carrer de Baldiri Reixac 15, 08028 Barcelona, Spain
Social Media

Finance Data

DateInvestorsAmountStage 
Jun 202312.000.000 €Seed
Sep 20211 €Seed

Financial Overview

No revenue recorded yet
Seed

CERCA ownership

CERCA Center Contact

Other Catalan Public owners

Logo

Status & Deeptech areas

Company Status & Company Deeptech Areas

Current company status

Current company status

DeepTech Area

DeepTech Area

Spinoff information

Company Description

Nuage Therapeutics mission is to leverage biomolecular condensation and chemical biology to develop selective inhibitors of intrinsically disordered proteins involved in challenging indications representing unmet medical needs.

Product description

The scientists behind Nuage Therapeutics have spent years investigating target proteins currently considered undruggable due to their unique structural properties. These targets have common surprising features, namely they are disordered, and can exert their activity through the formation of biomolecular condensates—dynamic protein droplets that regulate key processes and whose function is altered in several diseases.